RAMIPRIL (DirectRX)
Welcome to the PulseAid listing for the RAMIPRIL drug offered from DirectRX. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | DirectRX |
NON-PROPRIETARY NAME: | RAMIPRIL |
SUBSTANCE NAME: | RAMIPRIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-01-01 |
END MARKETING DATE: | 0000-00-00 |
RAMIPRIL HUMAN PRESCRIPTION DRUG Details:
Item Description | RAMIPRIL from DirectRX |
LABELER NAME: | DirectRX |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2015-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61919-179_3fb41bbb-ff2a-22c6-e054-00144ff8d46c |
PRODUCT NDC: | 61919-179 |
APPLICATION NUMBER: | ANDA077470 |
Other RAMIPRIL Pharmaceutical Manufacturers / Labelers: